TP53 and bladder transitional cell carcinoma: Besides, Kaplan−Meier analysis showed a clear trend that individuals with truncating TP53 mutation had longer survival time in BLCA (P-value = 0.12), PAAD (P-value = 0.24), and READ (P-value = 0.12), consistent with the results of previous published literature [13].